Sirona Biochem Corp. (CVE:SBM – Get Free Report) fell 18.8% during mid-day trading on Monday . The company traded as low as C$0.07 and last traded at C$0.07. 106,944 shares were traded during trading, an increase of 36% from the average session volume of 78,417 shares. The stock had previously closed at C$0.08.
Sirona Biochem Stock Performance
The firm’s fifty day simple moving average is C$0.07 and its 200 day simple moving average is C$0.06. The company has a market capitalization of C$16.69 million, a PE ratio of -6.50 and a beta of -0.03. The company has a debt-to-equity ratio of 219.21, a current ratio of 0.34 and a quick ratio of 2.41.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
See Also
- Five stocks we like better than Sirona Biochem
- How to Calculate Return on Investment (ROI)
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- 5 discounted opportunities for dividend growth investors
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Trading Stocks: RSI and Why it’s Useful
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
